Mingfeng Zhao

发表

Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies

Wenyi Lu, R. Guo, Yi Zhang, 2023, Current Treatment Options in Oncology.

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Elaine Tan Su Yin, D. Blaise, A. Nagler, 2019, Journal of Hematology & Oncology.

A combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma

Mingfeng Zhao, Xia Xiao, Yan-yu Jiang, 2022, Leukemia & lymphoma.

Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies

Jiaxing Wang, Mingfeng Zhao, X. Jin, 2022, Technology in cancer research & treatment.

Targeting BCMA to Treat Multiple Myeloma: Updates From the 2021 ASH Annual Meeting

Mingfeng Zhao, Wenyi Lu, Xinping Cao, 2022, Frontiers in Immunology.

Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma

Xiaoyuan He, Mingfeng Zhao, Wenyi Lu, 2019, Front. Oncol..

CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease

T. Sui, Mingfeng Zhao, Wenyi Lu, 2021, Cancer Immunology, Immunotherapy.

Optimization of metabolism to improve efficacy during CAR-T cell manufacturing

Jiaxi Wang, X. Jin, R. Sun, 2021, Journal of translational medicine.

Infection Temperature Affects the Phenotype and Function of Chimeric Antigen Receptor T Cells Produced via Lentiviral Technology

Mingfeng Zhao, Wenyi Lu, X. Jin, 2021, Frontiers in Immunology.

HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation

Xiaoyuan He, Lin Cheng, Mingfeng Zhao, 2019, Leukemia.

Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome

Tongtong Sun, Mingfeng Zhao, Wenyi Lu, 2021, Cancer science.

Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells

X. Bai, Mingfeng Zhao, Xia Xiao, 2014, Oncology letters.

Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing

Shengjin Fan, Zhiyang Yuan, Ting Yang, 2022, Cell transplantation.

Noninvasive tools based on immune biomarkers for the diagnosis of central nervous system graft-vs-host disease: Two case reports and a review of the literature

Mingfeng Zhao, Hairong Lyu, Xiaoyuan He, 2021, World journal of clinical cases.

Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia

Wenjian Ma, Sa Zhou, Hongpeng He, 2022, bioRxiv.

Metagenomic Next-Generation Sequencing versus Traditional Pathogen Detection in the Diagnosis of Peripheral Pulmonary Infectious Lesions

Jie Cao, Jing Feng, Donglin Yang, 2020, Infection and drug resistance.

Reactive oxygen species mediated T lymphocyte abnormalities in an iron-overloaded mouse model and iron-overloaded patients with myelodysplastic syndromes

Aiping Qi, Mingfeng Zhao, Deguan Li, 2017, Annals of Hematology.

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients

Wenyi Lu, Xia Xiao, J. Mu, 2022, Cell transplantation.

Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation

E. Jiang, Wenyi Lu, Mingzhe Han, 2019, Leukemia & lymphoma.

ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice

A. Meng, Jishi Wang, Yuchen Zhang, 2013, Scientific Reports.

Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1

Wenjian Ma, Sa Zhou, Mingfeng Zhao, 2022, bioRxiv.

Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.

Mingfeng Zhao, Wenyi Lu, Xia Xiao, 2020, Cytotherapy.

Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy

Jiaxing Wang, Wenyi Lu, Xia Xiao, 2023, Frontiers in Immunology.

Plasma Exchange Can Be an Alternative Therapeutic Modality for Severe Cytokine Release Syndrome after Chimeric Antigen Receptor-T Cell Infusion: A Case Report

Xiaoyuan He, Mingfeng Zhao, Xia Xiao, 2018, Clinical Cancer Research.

Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma

Yuekun Qi, A. Liang, K. Qi, 2022, Frontiers in Immunology.

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

He Huang, Yuekun Qi, Jianfeng Zhou, 2022, Blood.

Mitigating the Effects of Xuebijing Injection on Hematopoietic Cell Injury Induced by Total Body Irradiation with γ rays by Decreasing Reactive Oxygen Species Levels

Junling Zhang, A. Meng, Saijun Fan, 2014, International journal of molecular sciences.

Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways

X. Bai, Mingfeng Zhao, Xia Xiao, 2015, Experimental and therapeutic medicine.

Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair.

K. Tew, B. A. Schulte, Gavin Y. Wang, 2021, Free radical biology & medicine.

Diffuse Large B cell lymphoma with symptoms of renal failure at initial presentation

J. Mu, Yu-ming Li, Rajbhandary Sajin, 2013 .

Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients

A. Meng, Yan Jiang, Mingfeng Zhao, 2013, European journal of haematology.

Effects of Iron Overload on the Bone Marrow Microenvironment in Mice

A. Meng, Yuchen Zhang, Mingfeng Zhao, 2015, PloS one.

Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice

Hongyan Ni, Mingfeng Zhao, Wenyi Lu, 2018, Haematologica.

Corrigendum: ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice

A. Meng, Jishi Wang, Yuchen Zhang, 2017, Scientific Reports.

Metagenomic next-generation sequencing diagnosis of peripheral pulmonary infectious lesions through virtual navigation, radial EBUS, ultrathin bronchoscopy, and ROSE

Jie Cao, Jing Feng, Wenbin Cao, 2019, The Journal of international medical research.